rs41308435

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_206933.4(USH2A):​c.15076A>G​(p.Lys5026Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00887 in 1,614,214 control chromosomes in the GnomAD database, including 367 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.0061 ( 24 hom., cov: 32)
Exomes 𝑓: 0.0092 ( 343 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.72

Publications

17 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 39
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022268891).
BP6
Variant 1-215634680-T-C is Benign according to our data. Variant chr1-215634680-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0649 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.15076A>G p.Lys5026Glu missense_variant Exon 70 of 72 ENST00000307340.8 NP_996816.3 O75445-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.15076A>G p.Lys5026Glu missense_variant Exon 70 of 72 1 NM_206933.4 ENSP00000305941.3 O75445-1
USH2AENST00000674083.1 linkc.15076A>G p.Lys5026Glu missense_variant Exon 70 of 73 ENSP00000501296.1 O75445-3

Frequencies

GnomAD3 genomes
AF:
0.00608
AC:
926
AN:
152218
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00602
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.0292
Gnomad SAS
AF:
0.0708
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00342
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.0125
AC:
3137
AN:
251416
AF XY:
0.0155
show subpopulations
Gnomad AFR exome
AF:
0.000861
Gnomad AMR exome
AF:
0.00173
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.0187
Gnomad FIN exome
AF:
0.00300
Gnomad NFE exome
AF:
0.00376
Gnomad OTH exome
AF:
0.00896
GnomAD4 exome
AF:
0.00916
AC:
13384
AN:
1461878
Hom.:
343
Cov.:
32
AF XY:
0.0108
AC XY:
7848
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.000687
AC:
23
AN:
33480
American (AMR)
AF:
0.00215
AC:
96
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.0493
AC:
1958
AN:
39700
South Asian (SAS)
AF:
0.0680
AC:
5866
AN:
86258
European-Finnish (FIN)
AF:
0.00253
AC:
135
AN:
53418
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5768
European-Non Finnish (NFE)
AF:
0.00425
AC:
4721
AN:
1111998
Other (OTH)
AF:
0.00916
AC:
553
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
810
1620
2431
3241
4051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00609
AC:
928
AN:
152336
Hom.:
24
Cov.:
32
AF XY:
0.00749
AC XY:
558
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41576
American (AMR)
AF:
0.00601
AC:
92
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.0295
AC:
153
AN:
5190
South Asian (SAS)
AF:
0.0711
AC:
343
AN:
4826
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00342
AC:
233
AN:
68032
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00464
Hom.:
18
Bravo
AF:
0.00437
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00233
AC:
20
ExAC
AF:
0.0134
AC:
1626
Asia WGS
AF:
0.0480
AC:
167
AN:
3478
EpiCase
AF:
0.00431
EpiControl
AF:
0.00308

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Jul 05, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 19, 2010
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 18, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Jan 16, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2A Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 04, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa 39 Benign:1
Nov 04, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
11
DANN
Benign
0.49
DEOGEN2
Benign
0.016
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0012
N
LIST_S2
Benign
0.15
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-2.0
N
PhyloP100
1.7
PrimateAI
Benign
0.24
T
PROVEAN
Benign
1.0
N
REVEL
Benign
0.050
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.062
MPC
0.036
ClinPred
0.00052
T
GERP RS
3.9
Varity_R
0.067
gMVP
0.13
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41308435; hg19: chr1-215808022; API